Company Filing History:
Years Active: 2015
Title: Dhanalakshmi Sivanandhan: Innovator in Pharmaceutical Chemistry
Introduction
Dhanalakshmi Sivanandhan is a prominent inventor based in Noida, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. Her work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Dhanalakshmi holds a patent for "Biaryl imidazole derivatives for regulating CYP17." This patent presents novel imidazole compounds and their pharmaceutically acceptable salts. The application outlines methods for preparing these compounds, which are effective in inhibiting CYP17 activity. By administering a therapeutically effective amount of these compounds, various conditions associated with CYP17 activity can be treated. Notably, one of the diseases targeted by these compounds is cancer, including prostate cancer.
Career Highlights
Dhanalakshmi is currently associated with Asana Biosciences, LLC, where she continues to advance her research and development efforts. Her expertise in pharmaceutical chemistry has positioned her as a valuable asset in the industry.
Collaborations
Dhanalakshmi collaborates with esteemed colleagues, including Roger Astbury Smith and Nicholas James Laping. These partnerships enhance her research capabilities and contribute to the advancement of innovative therapeutic solutions.
Conclusion
Dhanalakshmi Sivanandhan is a trailblazer in the field of pharmaceutical chemistry, with a focus on developing compounds that can significantly impact cancer treatment. Her innovative work and collaborations continue to pave the way for advancements in healthcare.